ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO KNOW THE EARLY MANAGEMENT OF CLASS III MALOCCLUSION

AUTHORS:

Dr Haider Tahir, Dr Rida Tahir, Dr Mariam Tariq, Dr Sara Izhar, Dr Mohsin Majeed,

ABSTRACT:

Class III malocclusion presents a concave profile, dental mesococclusion, anterior crossbite and maxillary deficiency, skeletal imbalance, including mandibular excess or a combination. Instead of postponing treatment to older ages and treating the patient by camouflage or surgical procedures, the mild class III patients were chosen for early treatment with face mask, Frankel functional regulator, double-inverted block and mandibular inclined plane. The results were calm and encouraging. Objective: The aim of the study was to treat mild early class III malocclusion cases and evaluate the results of treated cases. Study Design: An analytical and observational Study. Place and duration: In the Department of Orthodontics, Nishtar Hospital, Multan for one year duration from February 2018 to February 2019. Method:. A total of 55 cases, 38 males and 17 females were selected to treat class III occlusion problems. The age of the patients ranged from 6 to 9 years. Patients were treated with functional instruments, curved mandibular planes and face masks. Results: The orthodontic treatment with orthopedic devices was mainly due to patient compliance, availability and cooperation, some patients could not complete the treatment. Therefore, we present the results of ten patients for each modality, which shows a significant improvement in tooth and skeletal problems. Conclusion: When functional braces were provided, it was concluded that young children with mild Class III problems may have better opportunities for camouflage treatment at later ages and that the need for surgery can be eliminated. Key words: Class III malocclusion, maxillary deficiency, mandibular excess, mandibular molar.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.